Results 201 to 210 of about 69,857 (321)

Detection Limits of Blood Metabolites at Physiological Concentrations Using Benchtop 1$$ {}^1 $$H NMR

open access: yesNMR in Biomedicine, Volume 39, Issue 2, February 2026.
We demonstrate rapid, sensitive detection of key blood metabolites using an 80 MHz low‐field NMR spectrometer, benchmarking signal‐to‐noise ratios and acquisition efficiency across experimental designs. Millimolar metabolites such as glucose and lactate are reliably detected and quantified within seconds, while simulation‐assisted spectral fitting ...
Alexander D. Hill   +4 more
wiley   +1 more source

Intestinal butyric acid-mediated disruption of gut hormone secretion and lipid metabolism in vasopressin receptor-deficient mice. [PDF]

open access: yesMol Metab
Harada K   +10 more
europepmc   +1 more source

Deceptive beauty of non‐natural structures

open access: yesProtein Science, Volume 35, Issue 2, February 2026.
Abstract Structures of proteins and multiprotein complexes are considered landmark achievements. However, in many cases, mutant proteins are used for structural work. Even when wild type proteins are used, crystallization or complex formation for cryoEM is performed in highly nonphysiological conditions.
Vsevolod V. Gurevich   +1 more
wiley   +1 more source

Recanting Twins: Addressing Intermediate Confounding in Mediation Analysis

open access: yesStatistics in Medicine, Volume 45, Issue 3-5, February 2026.
ABSTRACT The presence of intermediate confounders, also called recanting witnesses, is a fundamental challenge to the investigation of causal mechanisms in mediation analysis, preventing the identification of natural path‐specific effects. Common alternatives (such as randomizational interventional effects) are problematic because they can take non ...
Tat‐Thang Vo   +4 more
wiley   +1 more source

The Vasopressin Receptor Antagonist Tolvaptan Counteracts Tumor Growth in a Murine Xenograft Model of Small Cell Lung Cancer. [PDF]

open access: yesInt J Mol Sci
Naldi L   +9 more
europepmc   +1 more source

A snake toxin as a theranostic agent for the type 2 vasopressin receptor. [PDF]

open access: yesTheranostics, 2020
Droctové L   +20 more
europepmc   +1 more source

The novel vasopressin receptor (V1aR) antagonist SRX246 reduces anxiety in an experimental model in humans: a randomized proof-of-concept study. [PDF]

open access: yesPsychopharmacology (Berl), 2021
Lago TR   +12 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy